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Summary
The release of monoamine neurotransmitters from cell
bodies and dendrites has an important role in behav-
ior, but the mechanism (vesicular or nonvesicular)
has remained unclear. Because the location of vesicu-
lar monoamine transporter 2 (VMAT2) defines the se-
cretory vesicles capable of monoamine release, we
have studied its trafficking to assess the potential for
monoamine release by exocytosis. In neuroendocrine
PC12 cells, VMAT2 localizes exclusively to large
dense-core vesicles (LDCVs), and we now show that
cytoplasmic signals target VMAT2 directly to LDCVs
within the biosynthetic pathway. In neurons, VMAT2
localizes to a population of vesicles that we now find
undergo regulated exocytosis in dendrites. Although
hippocampal neurons do not express typical LDCV
proteins, transfected chromogranins A, B, and brain-
derived neurotrophic factor (BDNF) colocalize with
VMAT2. VMAT2 thus defines a population of secretory
vesicles that mediate the activity-dependent somato-
dendritic release of multiple retrograde signals in-
volved in synaptic function, growth, and plasticity.
Introduction
Unlike most classical neurotransmitters, monoamines
undergo release from the cell body and dendrites as
well as axon terminals (Geffen et al., 1976; Adell and Ar-
tigas, 1998). Somatodendritic dopamine release in the
ventral tegmental area is required for the induction of
behavioral sensitization to amphetamine, a model for
drug craving that involves the activation of presynaptic
D1 dopamine receptors (Vezina, 2004). In addition, do-
pamine release in the midbrain activates D2 autorecep-
tors that may contribute to the role of dopamine in motor
control (Cragg and Greenfield, 1997; Bergquist et al.,
2003). Somatodendritic serotonin release has also
been implicated in the autoregulation of dorsal raphe
excitability (Adell and Artigas, 1998). Somatodendritic
release thus contributes to the pathological role of do-
*Correspondence: edwards@itsa.ucsf.edupamine in drug abuse and presumably to the physiolog-
ical role of monoamines in normal behavior. However,
the mechanism of somatodendritic monoamine release
remains unclear.
Somatodendritic dopamine release may involve either
regulated exocytosis of vesicles containing transmitter
or efflux by a nonvesicular mechanism. Supporting an
exocytic mechanism, somatodendritic release pro-
duced by electrical stimulation may require Ca2+ and ve-
sicular storage of dopamine (Rice et al., 1997; Jaffe
et al., 1998; Beckstead et al., 2004). However, amphet-
amines are known to promote flux reversal mediated
by the plasma membrane dopamine transporter (DAT)
(Sulzer et al., 1995), and this may also require Ca2+
(Gnegy et al., 2004). Additional work has further sug-
gested that somatodendritic dopamine release is only
partially Ca2+ dependent and insensitive to the clostrid-
ial neurotoxins that cleave SNARE proteins required for
vesicle fusion (Chen and Rice, 2001; Bergquist et al.,
2002). A recent study has also indicated the sensitivity
of activity-dependent somatodendritic release to DAT
inhibitors (Falkenburger et al., 2001). On the other
hand, not all SNARE proteins are sensitive to the clos-
tridial toxins, and inhibition of DAT may also deplete ve-
sicular stores of monoamine (Giros et al., 1996).
To assess the potential for somatodendritic release of
monoamine by exocytosis, we have studied the traffick-
ing of the neuronal vesicular monoamine transporter 2
(VMAT2) because its location defines the vesicles capa-
ble of filling with monoamine and hence exocytic re-
lease. In contrast to the vesicular GABA and glutamate
transporters, which are almost exclusively axonal (Fre-
meau et al., 2004), VMAT2 localizes to the cell bodies and
dendrites as well as axon terminals of monoamine neu-
rons. In axons, VMAT2 localizes to synaptic vesicles and
large dense-core vesicles (LDCVs) (Nirenberg et al.,
1995). In cellbodiesand dendrites, the transporter resides
on poorly characterized tubulovesicular structures (Nir-
enberg et al., 1996), and it has remained unclear whether
these membranes undergo regulated exocytosis.
To understand the trafficking of VMAT2, we have used
heterologous expression in rat pheochromocytoma
PC12 cells. In PC12 cells, VMAT2 localizes exclusively
to LDCVs rather than to the synaptic-like microvesicles
that these cells also contain (Liu et al., 1994; Weihe
et al., 1994). Less abundant than synaptic vesicles in
neurons, LDCVs are the predominant class of secretory
vesicle in endocrine cells, contain proteins as well as
classical transmitters, and respond to different stimuli
than synaptic vesicles. LDCVs also differ from synaptic
vesicles in their biogenesis. Synaptic vesicles form lo-
cally at the nerve terminal: membrane proteins enter
synaptic vesicles only after arrival at the plasma mem-
brane (Regnier-Vigouroux et al., 1991; Takei et al.,
1995; Schmidt et al., 1997). In contrast, LDCVs bud di-
rectly from the trans-Golgi network (TGN) to form the
regulated (as opposed to constitutive) secretory path-
way (Arvan and Castle, 1998). However, little is known
about the mechanisms that sort membrane proteins
such as VMAT2 to synaptic vesicles or LDCVs.
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to rely on intralumenal aggregation and lipid interactions
(Zhang et al., 2003; Lou et al., 2005). Indeed, the abun-
dant secreted protein chromogranin A can drive the for-
mation of LDCVs in heterologous cells, apparently by
providing a nidus for aggregation in the lumen of the
vesicle (Kim et al., 2001). Nonetheless, the cytoplasmic
domains of several proteins including VMAT2 (Milgram
et al., 1994; Modderman et al., 1998; Blagoveshchen-
skaya et al., 1999; Krantz et al., 2000) also promote local-
ization to LDCVs. Targeting to LDCVs may therefore
involve a direct interaction with cytosolic sorting ma-
chinery, but it has remained unclear whether this inter-
action influences trafficking directly in the TGN or indi-
rectly by, for example, promoting retrieval to the TGN
after constitutive exocytosis.
Previous work has demonstrated that a C-terminal di-
leucine-like signal mediates the internalization of VMAT2
from the plasma membrane (Tan et al., 1998). In other
membrane proteins, acidic residues 4 and 5 positions
upstream of a dileucine signal have been found to be re-
quired for internalization (Pond et al., 1995; Dietrich
et al., 1997), and VMAT2 contains highly conserved glu-
tamates at these positions (KEEKMAIL). However, re-
placement of these residues (Glu-478 and Glu-479)
with alanine (mutant EE/AA) does not impair VMAT2 en-
docytosis (Tan et al., 1998). Rather, these residues influ-
ence other sorting events: the EE/AA mutation reduces
steady-state expression on LDCVs (Krantz et al., 2000),
implicating cytosolic rather than lumenal or membrane
interactions in sorting to the regulated secretory path-
way. On the other hand, the extended dileucine motif
might target VMAT2 to LDCVs simply by promoting its
retrieval to the TGN after misdelivery to the plasma
membrane.
We have now used metabolic labeling and pulse-
chase analysis to show that the extended dileucine motif
sorts VMAT2 directly to LDCVs within the biosynthetic
pathway, presumably at the level of the TGN. The same
mutations that disrupt sorting to LDCVs in PC12 cells
also increase cell-surface delivery in neurons, suggest-
ing that VMAT2 sorts to a regulated secretory pathway
in neurons as well. Moreover, we find that VMAT2 under-
goes regulated Ca2+-dependent exocytosis in dendrites
as well as at axon terminals. The EE/AA mutation that
disrupts sorting to LDCVs in PC12 cells eliminates the
regulated exocytosis of VMAT2 in dendrites but only par-
tially impairs its regulated exocytosis in axons. In addi-
tion, we have loaded hippocampal neurons expressing
VMAT2 with L-3,4-dihydroxyphenylanine (L-DOPA) and
used amperometry to confirm the quantal release of do-
pamine from cell bodies. Although hippocampal neurons
lack typical LDCV markers, transfected chromogranins
and brain-derived neurotrophic factor (BDNF) colocalize
with VMAT2. Neurons thus express a robust regulated
secretory pathway responsible for the dendritic release
of multiple retrograde synaptic signals.
Results
The Extended Dileucine-like Motif Targets VMAT2 to
LDCVs within the Biosynthetic Pathway
If sorting to LDCVs in the TGN were nonselective,
VMAT2 would enter nascent constitutive secretoryvesicles as well as LDCVs, and selective expression on
LDCVs would require multiple rounds of retrieval from
the plasma membrane to the TGN. Indeed, LDCV mem-
brane proteins do recycle to the TGN after exocytosis
(Hurtley, 1993). The extended dileucine-like motif might
thus indirectly affect localization to LDCVs by promoting
the retrieval of VMAT2 from the plasma membrane to the
TGN.
To distinguish between direct sorting to LDCVs in the
TGN and an indirect pathway involving retrieval from the
plasma membrane, we first assessed the rate of cell-
surface VMAT2 delivery by taking advantage of an epi-
tope tag (HA) inserted into the large lumenal loop
between transmembrane domains 1 and 2 (Tan et al.,
1998). PC12 cells stably expressing wild-type and mu-
tant VMAT2 were incubated with the mouse monoclonal
antibody HA.11 for 1 hr at 37ºC and were immunostained
with a secondary anti-mouse antibody to detect VMAT2
that had been delivered to the cell surface during that
time and with a rat HA antibody to assess total VMAT2
expression. Using this assay, wild-type VMAT2 cannot
be detected from the plasma membrane despite high
levels of total transporter expression (Figure 1A), sug-
gesting direct and efficient entry into LDCVs at the
TGN. Alternatively, the wild-type protein might not
remain on the plasma membrane long enough to be rec-
ognized by the external HA antibody. However, replace-
ment of Glu-478 and -479 upstream of the dileucine-like
signal by alanine (EE/AA mutation) results in the detec-
tion of substantial VMAT2 at the cell surface (Figure
1A). Since wild-type and EE/AA VMAT2 do not differ in
the rate of endocytosis (Tan et al., 1998), the failure to
detect wild-type protein at the plasma membrane can-
not reflect a difference from the EE/AA mutant in anti-
body access. Thus, any wild-type VMAT2 delivered to
the plasma membrane should also have been detected,
demonstrating that the wild-type protein sorts directly
to LDCVs and that this process depends on Glu-478
and -479. In addition, the IL/AA mutation affecting Ile-
483 and Leu-484 results in high levels of cell-surface
VMAT2 (Figure 1A), indicating a requirement for the
dileucine-like core signal as well as the upstream acidic
residues for direct targeting to LDCVs.
We extended the analysis to several other highly
conserved residues in VMAT2 that surround Glu-478
and -479 and have no role in endocytosis (Tan et al.,
1998). Alanine replacements of Lys-477 (K/A), and Lys-
480 and Met-481 (KM/AA) within the KEEKMAIL motif
do not appear to alter the localization of VMAT2 (Figure
1A). Like wild-type VMAT2, the K/A and KM/AA mutants
exhibit low levels of antibody uptake from the cell sur-
face (Figure 1A), suggesting that although highly con-
served, Lys-477, Lys-480, and Met-481 are not essential
for sorting to LDCVs. However, these antibody feeding
experiments assess steady-state delivery of VMAT2 to
the plasma membrane rather than the delivery of newly
synthesized protein.
We used metabolic labeling to determine whether
VMAT2 sorts directly to LDCVs within the biosynthetic
pathway. The sulfation of membrane proteins occurs
in the TGN (Tooze and Huttner, 1990), but the level of
VMAT2 labeling with 35S-sulfate was very low even after
the insertion of multiple sulfation signals (data not
shown). We therefore relied on biosynthetic labeling
Regulated Somatodendritic Exocytosis of VMAT2
621Figure 1. Wild-Type VMAT2 Sorts Directly to the Regulated Secretory Pathway
(A) PC12 cells stably expressing HA-tagged wild-type (wt), K477A (K/A), EE/AA, K480A/M481A (KM/AA), and IL/AA VMAT2 were incubated in
medium containing mouse HA.11 antibody for 1 hr at 37ºC, fixed, stained with rat monoclonal HA antibody followed by anti-mouse antibodies
conjugated to Cy5 and anti-rat antibodies conjugated to Cy3, and examined by confocal microscopy at the same sensitivity for all constructs.
Cells expressing wt, K/A, and KM/AA VMAT2 do not show significant HA antibody labeling relative to total protein expression, suggesting low
levels of VMAT2 delivery to the plasma membrane. In contrast, cells expressing EE/AA and IL/AA VMAT2 exhibit high levels of antibody binding,
indicating that a substantial proportion of these mutants is delivered to the plasma membrane.
(B) Cells were labeled with 0.5 mCi/ml 35S-cysteine/methionine for 30 min, then incubated for 1, 2, or 3 hr with unlabeled cysteine and methionine.
To determine how much 35S-labeled VMAT2 was delivered to the cell surface during each time interval, HA.11 antibody was added to the medium
of half the cells during the last hour of chase. The remaining cells were used to measure total 35S-labeled VMAT2. Total and cell-surface labeled
VMAT2 were then immunoprecipitated and submitted to autoradiography. Total protein (left) and cell-surface protein (right) are shown for wt,
EE/AA, and IL/AA VMAT2 at each chase time. Wild-type protein is virtually undetectable at the cell surface at all intervals. In contrast, EE/AA
and IL/AA mutants begin to appear at the cell surface within an hour of synthesis and continue to appear there for at least 3 hr.
(C) For each VMAT2 construct, the pulse-chase analysis shown in (A) was quantified, and for each interval, cell-surface-labeled VMAT2 was ex-
pressed as a fraction of total labeled VMAT2. Error bars represent standard error of the mean, with p < 0.05 for all the comparisons of EE/AA and
IL/AA mutants to wild-type at each time interval studied.in the endoplasmic reticulum with 35S-cysteine and -me-
thionine. Stably transfected cells were labeled for 30 min
with 35S-cysteine/methionine, then incubated in me-
dium containing unlabeled cysteine/methionine for 1,
2, or 3 hr. During the last hour of incubation, anti-HA an-
tibody was added to the medium of half the cells to de-
tect labeled VMAT2 that had arrived at the plasma mem-
brane within that time. Cell-surface and total 35S-labeled
VMAT2 were then immunoprecipitated from the cell ex-
tracts, separated by gel electrophoresis, and detected
by autoradiography. Using this assay, wild-type VMAT2
is essentially undetectable from the cell surface at alltime points tested (<20% total expression at 1–3 hr after
labeling) (Figures 1B and 1C). This could reflect direct
sorting to the regulated secretory pathway, but the pos-
sibility again remained that rapid internalization from the
plasma membrane might have reduced our ability to
detect cell-surface delivery of the newly synthesized
wild-type protein. Consistent with this possibility, the
internalization-defective IL/AA mutant is easily detected
from the plasma membrane (Figures 1B and 1C). How-
ever, a large proportion of the EE/AA mutant, which is
not defective in endocytosis (Tan et al., 1998), can also
be detected at the cell surface within 1 hr after labeling
Neuron
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culty detecting cell-surface delivery of newly synthe-
sized wild-type VMAT2, and the lack of wild-type VMAT2
at the cell surface indicates that the protein targets di-
rectly and selectively to the regulated secretory path-
way. Indeed, both IL/AA and EE/AA mutations result in
the rapid delivery of VMAT2 to the plasma membrane
early after biosynthesis, indicating diversion from regu-
lated to constitutive secretory vesicles. Since the IL/AA
mutation affects endocytosis as well as sorting to
LDCVs, the EE/AA mutation has a more selective func-
tion in targeting to the regulated secretory pathway.
The Extended DileucineMotif Regulates Cell-Surface
Delivery of VMAT2 in Neurons
To determine whether the extended dileucine motif tar-
gets VMAT2 to a regulated secretory pathway in neu-
rons, we used heterologous expression in dissociated
primary hippocampal culture. In contrast to the small
proportion of dopamine neurons in midbrain cultures,
hippocampal cultures yield a large number of relatively
uniform neurons amenable to transfection. To introduce
the VMAT2 cDNA into hippocampal neurons, we used
electroporation at the time of plating, which confers
modest, uniform expression in a large number of cells.
Similar to the endogenous expression by monoamine
neurons (Peter et al., 1995; Nirenberg et al., 1996),
wild-type VMAT2 shows robust somatodendritic ex-
pression in transfected hippocampal neurons. Double
staining for the synaptic vesicle protein SV2 (Figure
2B) confirms the anticipated synaptic localization of
VMAT2 in axons, but some of the strongest expression
colocalizes with the dendritic protein MAP2 (Figure 2A).
In contrast, vesicular glutamate transporters 1 and 2
remain axonal despite transfection (data not shown).
Similar to COS and PC12 cells (Tan et al., 1998), the
IL/AA mutant expressed in neurons shows more cell-
surface expression than wild-type VMAT2, on both ax-
ons and dendrites (Figure 2). However, the EE/AA mutant
shows a punctate distribution indistinguishable from
that of wild-type VMAT2 by steady-state immunofluo-
rescence.
We first double stained the transfected neurons for
secretogranin 2 to assess localization on LDCVs. How-
ever, hippocampal neurons express little if any of this
or other granins typically used as markers for LDCVs
(data not shown), and most of the secretogranin 2 in hip-
pocampal cultures is glial (Fischer-Colbrie et al., 1993;
Calegari et al., 1999). Because sorting to a regulated
secretory pathway reduces constitutive delivery to the
cell surface in PC12 cells, we examined the plasma-
membrane expression of VMAT2 in neurons by incubat-
ing the cultures in HA antibody conjugated directly to
the Alexa 488 fluorophore (HA-488). In cells labeled at
37ºC for 2 and 5 min (Figures 3A and 3B), wild-type
VMAT2 is barely detectable from the cell surface despite
high levels of total VMAT2 expression documented by
double staining for HA after permeabilization. In con-
trast, the IL/AA mutant shows robust cell-surface ex-
pression. In addition, the EE/AA mutation increases
cell-surface expression (Figure 3), although not as dra-
matically as the IL/AA substitution, and quantification
of the surface/total fluorescence confirms this result
(Figure 3B). To analyze the cell-surface expression ofVMAT2 biochemically, we used biotinylation of plasma-
membrane protein followed by Western analysis. Similar
to the immunofluorescence, wild-type VMAT2 shows lit-
tle cell-surface expression after normalization to total
transporter (Figures 3C and 3D). The IL/AA mutant
shows the most cell-surface expression, and the EE/AA
mutant is intermediate.
Since increased cell-surface expression may reflect
either an increase in exocytosis or a decrease in endocy-
tosis, we examined the rates of VMAT2 internalization in
the transfected hippocampal neurons. The chilled cells
were incubated in HA-488 at 4ºC, then warmed for vary-
ing times to allow internalization, and the remaining cell-
surface fluorophore quenched with an external rabbit
antibody to Alexa 488 before permeabilization. Un-
quenchable HA-488 fluorescence thus reflects internal-
ized VMAT2. Figure 4A illustrates the endocytosis
observed after 10 min at 37ºC, and we quantified the sur-
face/total fluorescence using multiple cultures at a range
of time points (Figure 4B). Wild-type VMAT2 exhibits lit-
tle cell-surface expression, but the fluorescence that is
detected begins to resist quenching after 2 and 5 min
of internalization. On the other hand, almost all of the flu-
orophore bound to the endocytosis-defective IL/AA mu-
tant remains quenchable up to 20 min after the start of
internalization (Figure 4). The dramatic difference be-
tween unquenched and quenched IL/AA mutant indeed
demonstrates the efficiency of quenching. Unlike the
IL/AA mutant, the EE/AA mutant begins to internalize
around 5 min (Figure 4). Although perhaps slightly de-
layed, endocytosis of the EE/AA mutant therefore re-
sembles that of the wild-type protein, consistent with
previous results in PC12 cells (Tan et al., 1998). Because
the EE/AA mutation increases cell-surface expression
without substantially affecting endocytosis, it must in-
crease cell-surface delivery. Although hippocampal
neurons contain few LDCVs, at least by staining for the
granins (Fischer-Colbrie et al., 1993; Calegari et al.,
1999), the results raise the possibility that the EE/AA
mutation diverts VMAT2 from regulated into constitu-
tive secretory vesicles in neurons as well as in PC12
cells.
Regulated Exocytosis of VMAT2 in Dendrites
and Axons
To determine whether VMAT2 resides on regulated se-
cretory vesicles in dendrites as well as in axons, we
stimulated the transfected cultures by depolarization.
In the absence of depolarization, wild-type VMAT2 is
barely detectable from the cell surface after incubation
for 2 min in Tyrode’s medium containing HA-488 (Figure
5A, upper panels). In Tyrode’s medium containing 90
mM KCl and Ca2+, however, HA-488 strongly labels syn-
aptophysin+ axon terminals and synaptophysin2 den-
drites (Figure 5A, middle panels). The absence of Ca2+
eliminates the increase in cell-surface VMAT2 at both
sites (Figure 5A, bottom panels). Quantitation of the sur-
face to total VMAT2 fluorescence in multiple indepen-
dent experiments confirms that wild-type VMAT2 under-
goes regulated, Ca2+-dependent exocytosis at cell
bodies and dendrites as well as axon terminals (Figure
5C). In contrast, the EE/AA mutant shows increased
baseline cell-surface expression in axons and den-
drites that increases further upon stimulation only in the
Regulated Somatodendritic Exocytosis of VMAT2
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Type and Mutant VMAT2 in Transfected Hip-
pocampal Neurons
(A) Hippocampal cultures transfected with
wt, EE/AA, and IL/AA VMAT2 cDNAs were
double stained with a rat antibody to the HA
epitope (Aa, Ad, and Ag) and a mouse anti-
body to MAP2 (Ab, Ae, and Ah), followed by
secondary anti-rat antibodies conjugated to
FITC and anti-mouse antibodies conjugated
to Cy3. Both wt and mutant VMAT2 colocalize
with MAP2 in the cell body and dendrites (Ac,
Af, and Ai). Unlike the internalization-defec-
tive IL/AA mutant, which exhibits high-level
expression at the plasma membrane (Ag–
Ai), the EE/AA shows a punctate cytoplasmic
expression pattern similar to wt VMAT2 (Aa–
Ac and Ad–Af).
(B) Transfected hippocampal cultures were
double stained with rat HA antibody (Ba,
Bd, and Bg) and mouse antibody to SV2
(Bb, Be, and Bh), followed by secondary
anti-rat antibody conjugated to FITC and
anti-mouse antibody conjugated to Cy3. The
IL/AA mutant shows increased cell-surface
expression (Bg–Bi), but the EE/AA mutant
has a punctate localization (Bd–Bf) similar to
wt VMAT2 (Ba and Bc). The arrows in (Ba)–
(Bf) indicate sites of VMAT2 colocalization
with SV2. Scale bar, 10 mm.axons (Figure 5B). Quantitation confirms that the EE/AA
mutation eliminates regulated exocytosis of the trans-
porter in dendrites but only partially impairs its regulated
exocytosis in axons (Figure 5C). Thus, the extended di-
leucine motif is important for regulated somatodendritic
exocytosis in neurons.
To confirm that VMAT2 can mediate the release of do-
pamine at somatodendritic sites, we measured dopa-
mine release directly by amperometric recording. Tak-ing advantage of the heterologous VMAT2 expression,
we loaded the transfected hippocampal neurons with
catecholamine by incubating them in L-DOPA, the pre-
cursor for dopamine. As we showed previously, this
compound can undergo conversion to dopamine by en-
dogenous decarboxylases even in cells not normally
monoaminergic and confer quantal dopamine release
if these cells also express VMAT2 (Pothos et al., 2000).
A GFP fusion to the N terminus of VMAT2 was used to
Neuron
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(A) Transfected hippocampal neurons expressing HA-tagged wt, EE/AA, and IL/AA VMAT2 were incubated with HA antibody conjugated directly
to Alexa 488 (HA-488) for 2 min at 37ºC, then chilled, fixed, and immunostained with HA.11 and secondary anti-mouse antibodies conjugated to
Cy3 for total VMAT2 expression. EE/AA and IL/AA mutants show substantially more surface expression than wt VMAT2. Scale bar, 20 mm.
(B) After incubation in HA-488 for 2 and 5 min as described above, quantitation of the surface-labeled and total fluorescence from 40 to 65 pro-
cesses of 12 to 14 neurons for each construct shows substantially more cell-surface EE/AA and IL/AA than wt VMAT2. The results are normalized
to 100% for the IL/AA mutant, and bars represent mean 6 SEM, p < 0.01 between wt and EE/AA as well as between wt and IL/AA VMAT2.
(C) Transfected hippocampal neurons expressing HA-tagged wt, EE/AA, and IL/AA VMAT2 were biotinylated on ice and the biotinylated proteins
immunoblotted with anti-HA antibody 3F10. In a representative experiment, EE/AA and IL/AA mutants show more cell-surface expression than
wt VMAT2 (upper panel). The lower panel shows total VMAT2 protein in the transfected cells. Molecular weight markers are shown at the left in
kDa.
(D) Normalization of cell surface to total VMAT2 determined by quantitative Western analysis confirms the increased cell-surface expression of
EE/AA and IL/AA mutants. The values represent the mean of surface/total expression in arbitrary units (AU)6 SEM (n = 3). *p < 0.05 between wt
and EE/AA and **p < 0.01 between wt and IL/AA VMAT2.guide placement of the 5 mm diameter carbon fiber elec-
trode over transfected cells (Figure 6A), which were
stimulated by local perfusion with high potassium. Im-
portantly, we recorded over cell bodies rather than den-
drites to exclude potential confusion with axonal pro-
cesses. In addition, cell bodies without adjacent GFP+
processes were chosen to exclude contamination by ax-
onal release. Of 54 GFP-labeled transfected cells, 8 dis-
played quantal release events following stimulation (Fig-
ure 6B), whereas of 36 untransfected (GFP2) cells, none
displayed such events, a statistically significant differ-
ence (Table 1). Thus, the amperometry demonstrates
that VMAT2 confers the regulated somatodendritic re-
lease of dopamine. The frequency of events may seem
low, but detection requires placement of the electrode
directly over a release site, and even axonal events are
detected at low frequency in midbrain culture after de-
polarization with K+ (Staal et al., 2004).The kinetics of transmitter release from transfected
hippocampal cell bodies were similar to quantal events
measured from small synaptic vesicles at the terminals
of cultured dopamine neurons, with a duration at
half-maximal amplitude (t1/2) w100 ms (Table 1) (Staal
et al., 2004). In contrast, the LDCVs of chromaffin,
mast, and PC12 cells release their contents over tens
to hundreds of milliseconds (Travis and Wightman,
1998). The mean quantal size of neurotransmitter re-
leased from hippocampal cell bodies was 2- to 4-fold
larger than that recorded from dopamine terminals,
but still substantially smaller than release from LDCVs.
Thus, the somatic quanta observed here do not resem-
ble release from LDCVs, consistent with the predomi-
nant localization of VMAT2 to somatodendritic tubulove-
sicular membranes that lack a dense core. Nonetheless,
the localization of VMAT2 to both LDCVs and somato-
dendritic secretory vesicles, both of which undergo
Regulated Somatodendritic Exocytosis of VMAT2
625Figure 4. EE/AA and Wild-Type VMAT2 Internalize at Similar Rates in Neurons
(A) Hippocampal cultures transfected with HA-tagged VMAT2 cDNAs were incubated with HA-488 for 30 min at 4ºC, warmed to 37ºC for 10 min,
and the remaining cell-surface HA-488 either quenched with external rabbit anti-488 antibody or not quenched. The total amount of transporter
expressed was determined by immunostaining with HA.11 and Cy3-conjugated secondary anti-mouse antibodies. The Alexa 488 fluorescence in
unquenched cultures represents the total HA-488 fluorophore bound to VMAT2. The unquenchable Alexa 488 fluorescence in quenched cultures
reflects the extent of VMAT2 internalization. The difference between quenched and unquenched therefore indicates the amount of transporter
still at the plasma membrane. Wild-type VMAT2 exhibits low levels of cell-surface expression despite high levels of total transporter expressed.
The IL/AA mutant shows high levels of plasma-membrane expression that remain almost entirely quenchable at 10 min of internalization, indi-
cating the efficiency of the quenching procedure. The EE/AA mutant exhibits intermediate levels of cell-surface expression that resist quenching.
Scale bars, 20 mm.
(B) Quantitation of the surface/total fluorescence from 160 to 200 puncta of 6 to 12 neurons for each time point of internalization. Despite low
levels of cell-surface expression, wt VMAT2 exhibits quenchable fluorescence at 0 and 2 min that becomes resistant to quenching by 5 min.
The EE/AA and IL/AA mutants show substantially more labeling than wt VMAT2 (note the difference in scale), but the fluorescence of EE/AA be-
comes unquenchable by 5 min, whereas that of IL/AA remains quenchable after 20 min of internalization. Error bars represent SEM.regulated exocytosis, and the similar effects of the EE/
AA mutation on sorting to both of these vesicle popula-
tions, suggest that, despite the absence of a dense core,
the VMAT2+ vesicles in neuronal dendrites represent the
functional equivalent of LDCVs.
To assess further the relationship between somato-
dendritic VMAT2+ vesicles and LDCVs, we cotrans-
fected chromogranin A and B cDNAs into hippocampal
neurons (separately) along with that for VMAT2. Double
staining showed a very similar distribution of chromog-
ranin A (data not shown) and B with VMAT2 in both cellbodies and processes (Figures 7A–7C), supporting the
functional similarity of somatodendritic vesicles to
LDCVs. What else do the somatodendritic VMAT2+
vesicles release? Considerable previous work has
described the regulated release from neurons and in
particular from dendrites of neurotrophins such as
BDNF (Wetmore et al., 1994; Mowla et al., 1999; Horch
and Katz, 2002; Brigadski et al., 2005). To determine
the relationship of VMAT2+ vesicles to those releas-
ing BDNF, we cotransfected the BDNF and VMAT2
cDNAs. Double labeling demonstrates the extensive
Neuron
626Figure 5. Depolarization Stimulates the Ca2+-Dependent Exocytosis of VMAT2 in Axons and Dendrites, and the EE/AA Mutation Selectively Elim-
inates Regulated Dendritic Exocytosis
Hippocampal neurons transfected with HA-tagged wt (A) and EE/AA (B) VMAT2 cDNAs were labeled for 2 min at 37ºC from the cell surface with
HA-488. Unstimulated cells were incubated in standard Tyrode’s medium containing HA-488 ([A and B], upper panels). Neurons were stimulated
in Tyrode’s medium containing 90 mM KCl in the presence ([A and B], middle panels) and absence ([A and B], lower panels) of 2 mM Ca2+. The
cells were then fixed and immunostained for total VMAT2 (red) and synaptophysin (blue). Cell-surface VMAT2 bound to Alexa 488 is shown in
green, and the inset shows a 53magnification of the designated box. Arrows indicate VMAT2+/synaptophysin+ axon terminals and arrowheads
VMAT2+/synaptophysin2 puncta in dendrites (insets). Yellow indicates the colocalization of surface and total VMAT2 expression, and white the
colocalization of surface, total VMAT2, and synaptophysin. In the absence of stimulation ([A], upper panels), wt VMAT2 is barely detectable at the
surface of axons and dendrites. Depolarization dramatically increases cell-surface expression of wt VMAT2 at axon terminals and dendrites, and
the increase depends on external Ca2+ (compare middle and lower panels in [A]). Without stimulation, the EE/AA mutant shows more expression
on the surface of axons and dendrites ([B], upper panels) than wt VMAT2 ([A], upper panels). Depolarization increases surface expression of the
EE/AA mutant on axons but not dendrites, and the increase also depends on Ca2+ (compare middle and lower panels in [B]). Scale bar, 20 mm.
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627colocalization of these two proteins (Figures 7D–7F). In
contrast, the endosomal protein EEA1 implicated in den-
dritic membrane trafficking (Wilson et al., 2000) exhibits
a distribution distinct from VMAT2 (Figures 7G–7I), indi-
cating the specificity of VMAT2 for the biosynthetic as
opposed to the endocytic pathway in dendrites. In addi-
tion, since postsynaptic glutamate receptors undergo
regulated membrane trafficking that underlies certain
forms of synaptic plasticity, we double stained for the
glutamate receptor subunit GluR1 and for the postsyn-
aptic density protein PSD95, which associates with glu-
tamate receptors (Bredt and Nicoll, 2003). The distribu-
tion of both PSD95 and GluR1 appears different from
VMAT2 (Figures 7J–7O), confirming that wild-type
VMAT2 resides on a distinct population of regulated se-
cretory vesicles.
Figure 6. Amperometric Recording of Quantal Somatic Events from
Hippocampal Neurons Transfected with VMAT2 and Loaded with
L-DOPA
(A) Hippocampal neurons were transfected at 1 week in vitro with
a fusion of GFP to the N terminus of VMAT2 and examined 1 week
later, after loading them for 1 hr with 100 mM L-DOPA. The red circle
shows the approximate size and position of the amperometric elec-
trode over a GFP+ cell body. Note the absence of overlying GFP+
processes. Scale bar, 5 mm.
(B) Amperometric current recorded from the neuronal cell body
shown in (A). The neuron was depolarized by local application of
40 mM KCl solution for 10 s. Three events are shown below at an ex-
panded time scale.Discussion
The results show that in PC12 cells, wild-type VMAT2 is
essentially undetectable from the cell surface, consis-
tent with direct targeting to LDCVs. However, the IL/
AA mutation increases cell-surface delivery of the trans-
porter and impairs its endocytosis, raising the alterna-
tive possibility that the dileucine-like signal targets
VMAT2 to LDCVs by promoting its retrieval from the
plasma membrane to the TGN. We now show that the
EE/AA mutation also increases cell-surface delivery of
VMAT2 but without affecting endocytosis. Since wild-
type and EE/AA VMAT2 internalize at similar rates, the
failure to detect wild-type protein on the cell surface
demonstrates that it sorts directly to LDCVs without
passage through the constitutive secretory pathway to
the plasma membrane. The metabolic labeling of newly
synthesized protein confirms that the extended dileu-
cine-like motif targets VMAT2 directly to LDCVs within
the biosynthetic pathway, presumably at the level of
the TGN. In contrast to Ile-483 and Leu-484, which influ-
ence multiple trafficking events including endocytosis
as well as sorting to LDCVs, Glu-478 and -479 thus
have a specific role in targeting VMAT2 to the regulated
secretory pathway (Figure 8).
The results provide evidence that cytoplasmic se-
quences target a membrane protein directly to LDCVs
within the biosynthetic pathway. As a consequence,
they refocus attention on the role of cytosolic sorting
machinery in LDCV biogenesis. The dileucine-like core
of the trafficking motif in VMAT2 suggests an interaction
with the family of adaptor proteins (APs or adaptins),
which are known to bind both tyrosine- and dileucine-
based motifs (Rapoport et al., 1998; Robinson and Boni-
facino, 2001). Consistent with a possible role in sorting
to LDCVs, AP-1, -3, and -4 localize to the TGN (Robinson
and Bonifacino, 2001); however, the role of upstream
acidic residues in recognition by these adaptors
remains unclear. The monomeric Golgi-localized, g-
ear-containing, ARF binding proteins (GGAs) require up-
stream acidic residues for recognition of a dileucine mo-
tif in cargo proteins such as the mannose-6-phosphate
receptor (Puertollano et al., 2001; Zhu et al., 2001). On
the other hand, they depend primarily on an acidic resi-
due three positions upstream of the dileucine and thus
would be unlikely to recognize the dileucine-like se-
quence in VMAT2 with acidic residues four and five
positions upstream. Sorting to LDCVs may therefore re-
quire interaction with other, perhaps unidentified adap-
tor proteins.
In several proteins, acidic residues upstream of dileu-
cine motifs can influence endocytosis (Dietrich et al.,
1994; Pond et al., 1995). Our results now suggest a po-
tential role for these residues in other trafficking events
such as sorting to the regulated secretory pathway. In-
terestingly, mutations in the residues upstream of a
tyrosine-based motif redistribute P-selectin away from(C) Quantitation of surface/total fluorescence at cell bodies and dendrites (upper panel) and at axons (lower panel) for wt and EE/AA VMAT2 with-
out and with depolarization in the presence and absence of Ca2+. Total VMAT2+ puncta were first identified in axons and dendrites (excluding
puncta that were not in close proximity to the plasma membrane in these confocal sections), and the ratio of cell-surface/total VMAT2 fluores-
cence was then quantified. 180 to 300 axonal and 160 to 200 somatodendritic puncta from 15 to 20 neurons were analyzed. Bars represent mean
of surface/total fluorescence 6 SEM. *p < 0.001.
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628Table 1. Parameters of Amperometric Events from Hippocampal Cultures Transfected with GFP-VMAT2, Treated 1 Week Later with
100 mM L-DOPA and Stimulated with 40 mM KCl
Peak Height (pA) t1/2 (ms) # Molecules # Active Cells/Total # Cells # Events/Cell
Transfected 46 6 10 138 6 22 39653 6 18463 8/54 7.0 6 2.1
Untransfected — — — 0/36* 0
For isolated GFP+ cell bodies, the results indicate the mean of the average values from each recorded cell6SEM (n = 8 cells). GFP2 cells (untrans-
fected) in the same cultures showed no amperometric events. *denotes significant difference from transfected neurons by c2 analysis, p = 0.16.LDCVs in mouse pituitary AtT-20 cells, although not in
PC12 cells (Modderman et al., 1998; Blagoveshchen-
skaya et al., 1999). A tyrosine-based signal also appears
to influence sorting of the protein phogrin to LDCVs
(Wasmeier et al., 2005). However, phogrin contains an
additional C-terminal sequence (AEEVNAIL) remarkably
similar to the extended dileucine-like motif in VMAT2
(KEEKMAIL), and it will be interesting to determine
whether this sequence also controls sorting to LDCVs.
Consistent with this possibility, Lys-477, Lys-480, and
Met-481 (KEEKMAIL) of VMAT2 do not seem to be im-
portant for targeting to the regulated pathway, and these
are the same residues divergent between VMAT2 and
phogrin.
The extended dileucine motif that promotes traffick-
ing to LDCVs in PC12 cells also influences VMAT2 local-
ization in neurons. Similar to the results in other cells, the
IL/AA mutation greatly increases cell-surface expres-
sion by reducing the rate of internalization. The EE/AA
mutation moderately increases cell-surface expression
but has minimal effect on endocytosis. In the absence
of a change in endocytosis, the increased cell-surface
expression of EE/AA VMAT2 must result from increased
cell-surface delivery. Increased constitutive exocytosis
of this mutant in neurons, together with its diversion
from the regulated to constitutive secretory pathway in
PC12 cells, indeed suggest that wild-type VMAT2 also
sorts directly to a regulated secretory pathway in neu-
rons (Figure 8). However, hippocampal neurons contain
very few LDCVs, and in culture they do not stain for typ-
ical LDCV markers (Fischer-Colbrie et al., 1993; Calegari
et al., 1999).
To assess the regulated exocytosis of VMAT2 in neu-
rons, we depolarized transfected hippocampal cultures
and monitored cell-surface delivery of the wild-type
transporter. Depolarization dramatically increases the
plasma-membrane expression of wild-type VMAT2,
and this increase depends on external Ca2+, consistent
with vesicular release. Further, VMAT2 undergoes regu-
lated exocytosis at dendrites as well as at axon termi-
nals. VMAT2 thus defines a previously uncharacterized
class of secretory vesicles without typical LDCV
markers that apparently correspond in function to
LDCVs (Figure 8). Indeed, Glu-478 and -479, the same
residues that promote sorting to LDCVs in PC12 cells,
also direct VMAT2 to regulated somatodendritic secre-
tory vesicles in neurons. The EE/AA mutation increases
constitutive cell-surface delivery of VMAT2 in neurons
and abolishes the increase in somatodendritic exocyto-
sis produced by depolarization. In contrast, the EE/AA
mutation reduces but does not eliminate regulated exo-
cytosis in axons. The regulated secretory pathway to
which VMAT2 localizes in neurons may therefore exist
at axon terminals as well as at dendrites (Figure 8, lowerpanel), as previously suggested from studies of mono-
amine neurons (Thureson-Klein, 1983; Nirenberg et al.,
1995). However, localization of EE/AA VMAT2 to synap-
tic vesicles still enables its regulated exocytosis at ax-
ons, whereas the absence of an alternative pathway
eliminates regulated exocytosis of the mutant in den-
drites (Figure 8).
Persistent regulated exocytosis of the EE/AA mutant
at axon terminals suggests that Glu-478 and -479 are
not required for the trafficking of VMAT2 to synaptic
vesicles. Consistent with this, EE/AA but not wild-type
VMAT2 localizes to a population of light vesicles in
PC12 cells (Krantz et al., 2000). Since synaptic vesicles
form at the plasma membrane, the low rate of cell-
surface delivery apparently restricts the opportunity for
wild-type VMAT2 to enter synaptic vesicles. The IL/AA
mutation increases cell-surface expression, but also im-
pairs internalization and thus blocks sorting to synaptic
vesicles at a different step. In contrast, the EE/AA muta-
tion increases plasma-membrane delivery without im-
pairing endocytosis or sorting to synaptic vesicles (Fig-
ure 8). Glu-478 and -479 are thus required specifically
for trafficking to the regulated secretory pathway (LDCVs
in endocrine cells) but not to synaptic vesicles.
To confirm the regulated exocytosis of VMAT2 at cell
bodies and dendrites, we took advantage of the heterol-
ogous expression in hippocampal neurons to load do-
pamine into secretory vesicles containing VMAT2 and
monitor dopamine release directly by amperometry. Fo-
cusing on transfected cell bodies without adjacent GFP+
processes to avoid confusion of axonal with dendritic
processes, we observed quantal release from a substan-
tial fraction of those recorded. Because the carbon fiber
electrode can detect dopamine released only from im-
mediately adjacent sites, this underestimates the true
proportion of cell bodies capable of exocytic release.
The events appeared 2- to 4-fold larger than synaptic
vesicle quanta and much smaller than events associated
with conventional LDCVs. However, it is difficult to inter-
pret discrepancies in quantal size because we have
relied on loading with exogenous L-DOPA in this heter-
ologous expression system rather the endogenous pro-
duction of L-DOPA by tyrosine hydroxylase in native
monoamine neurons. On the other hand, the quantal
events recorded at cell bodies are very brief, much
more similar in duration to axonal release from synaptic
vesicles than from LDCVs, which are 2 to 3 orders of
magnitude longer. Since release from the dense core ac-
counts for the prolonged events observed in chromaffin
cells, the brevity of events described here supports the
absence of a dense core from most regulated secretory
vesicles in neurons. This does not exclude the existence
of a small fraction of vesicles with a dense core, as
previously observed in midbrain dopamine neurons
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629Figure 7. VMAT2 Colocalizes with Cotransfected Chromogranins and BDNF
Hippocampal neurons were transfected with cDNAs for chromogranin B (CgB) fused to YFP (A–C), or brain-derived neurotrophic factor (BDNF)
fused to GFP (D–F), along with the cDNA for HA-tagged wt VMAT2. After 12–18 days in vitro, the cells were double stained for YFP or GFP using
a rabbit GFP antibody and a secondary antibody conjugated to FITC, and for HA-tagged VMAT2 using either a mouse or rat primary antibody and
corresponding secondary antibodies conjugated to either Cy3 or Cy5. Endogenous endosomal antigen EEA1 (G–I), the postsynaptic density pro-
tein PSD95 (J–L), and the glutamate receptor subunit GluR1 (M–O) were labeled using mouse antibodies to EEA1 and PSD95, and a rabbit
antibody to GluR1. VMAT2 colocalizes extensively with CgB and BDNF but exhibits a distribution distinct from EEA1, PSD95, and GluR1. The
merged image shows HA-VMAT2 in red and the others in green. Scale bar, 20 mm.(Nirenberg et al., 1996), but the results do suggest that
the more abundant vesicles without a dense core can
also undergo regulated exocytosis and apparently con-
fer most of the release from this secretory pathway.
Recent work has demonstrated the regulated exocy-
tosis of membrane and secreted proteins at dendrites.
Long-term potentiation involves the insertion of
AMPA-type glutamate receptors into the postsynaptic
membrane, but these receptors derive from a pool of re-cycling endosomes (Bredt and Nicoll, 2003) rather than
the biosynthetic pathway. Consistent with this differ-
ence, the subcellular distribution of VMAT2 does not
resemble that of endosomal protein EEA1, the AMPA re-
ceptor subunit GluR1, or the associated PSD95. On the
other hand, the secretion of soluble proteins such as
growth factors must derive from the biosynthetic path-
way, and repeated observations have demonstrated
the depolarization-dependent release of neurotrophins
Neuron
630from a variety of cell types, including PC12 cells and hip-
pocampal neurons (Edwards et al., 1988; Wetmore et al.,
1994; Heymach et al., 1996; Mowla et al., 1999; Balko-
wiec and Katz, 2002; Brigadski et al., 2005). In addition,
neurotrophins have been found to reside within a distinct
population of secretory vesicles that also contain the
Ca2+-dependent activator proteins for secretion
(CAPS1 and 2) required specifically for the exocytosis
of LDCVs (Tandon et al., 1998; Sadakata et al., 2004).
We now find that, after cotransfection, VMAT2 indeed
colocalizes extensively with BDNF in axons and den-
drites, and BDNF, like VMAT2, undergoes exocytosis
at axon terminals as well as dendrites (Kohara et al.,
2001). Taken together, the results indicate that VMAT2
and BDNF sort to the same population of regulated se-
cretory vesicles. Finally, we have cotransfected the hip-
pocampal neurons with chromogranins A and B and find
Figure 8. Model of VMAT2 Trafficking in PC12 Cells and Neurons
In PC12 cells (top panels), wt VMAT2 (left) sorts directly and specif-
ically to LDCVs at the level of the TGN. LDCVs do not fuse with the
plasma membrane in the absence of stimulation (increased cyto-
plasmic Ca2+) and hence wt VMAT2 does not have the opportunity
to reach the synaptic-like microvesicles (SLMVs) of PC12 cells,
which form at the cell surface. In contrast, EE/AA and IL/AA
VMAT2 (right) both traffick to constitutive secretory vesicles
(CSVs), which undergo spontaneous, unstimulated exocytosis. Con-
stitutive exocytosis allows the EE/AA mutant to enter SLMVs, but the
IL/AA mutant has a defect in endocytosis, blocking entry to SLMVs
and trapping the protein on the plasma membrane. In neurons (bot-
tom panels), VMAT2 localizes to regulated secretory vesicles (RSVs)
functionally similar to LDCVs but without secretogranin+ cores.
VMAT2 also localizes to synaptic vesicles (SVs), suggesting either
that the stimulated exocytosis of RSVs allows access to the plasma
membrane and entry to SVs, or that the wild-type protein sorts to
CSVs as well as to RSVs in these cells. Since axons (left) contain
both SVs and RSVs but dendrites (right) contain only RSVs, the
EE/AA mutation that impairs sorting to RSVs but not SVs reduces
the regulated VMAT2 exocytosis at axons, and eliminates its regu-
lated exocytosis at dendrites.that, despite the absence of endogenous chromogranin
in hippocampal neurons, the introduced proteins also
colocalize extensively with VMAT2. VMAT2 and BDNF
thus sort to a population of regulated secretory vesicles
that resemble LDCVs in many respects, such as biogen-
esis and regulated exocytosis, but lack the usual com-
ponents of a dense core.
In summary, we find that neurons express a regulated
secretory pathway much more extensive than previ-
ously anticipated from the identification of LDCVs. Spe-
cific cytoplasmic signals target the membrane protein
VMAT2 directly to this pathway, focusing attention on
the role of cytosolic machinery in the biogenesis of these
vesicles. Trafficking of VMAT2 to the regulated secretory
pathway in neurons also confers the regulated somato-
dendritic release of monoamine by exocytosis, and ma-
nipulating the pathway will allow us to assess the role of
somatodendritic release in behavior. Further, colocali-
zation of VMAT2 with BDNF suggests a general role for
this regulated secretory pathway in the release of multi-
ple retrograde signals required for activity-dependent
synaptic growth and plasticity.
Experimental Procedures
Molecular Biology
For expression in neurons, all cDNAs were subcloned under the con-
trol of the chicken actin promoter (a generous gift of J.L. Ruben-
stein). Chromogranin A (CgA)-YFP and B (CgB)-YFP were produced
by inserting CgA and CgB cDNAs into the pEYFP-N3 vector (Clon-
tech). BDNF-GFP was a generous gift of B. Lu (NINDS).
PC12 Cell Culture and Immunofluorescence
PC12 cell culture, transfection, and immunofluorescence were per-
formed as described (Krantz et al., 2000). To assess internalization,
cells treated with NGF (50 ng/ml) for 2–3 days were incubated for 1 hr
at 37ºC with anti-HA mouse monoclonal antibody HA.11 (Covance),
washed, fixed, and stained with the anti-HA rat monoclonal antibody
3F10 (Roche), followed by secondary anti-mouse antibodies conju-
gated to Cy5 and anti-rat antibodies conjugated to Cy3. All fluores-
cence was detected by confocal laser microscopy.
Pulse-Chase Analysis and Immunoprecipitation
PC12 cells were labeled for 30 min at 37ºC in cys- and met-free me-
dium containing 0.5 mCi/ml 35S-cys/met, washed, and incubated at
37ºC in the same medium for 1–3 hr. To detect 35S-labeled VMAT2 on
the plasma membrane, HA.11 antibody (1:100) was added to the me-
dium of half the cells during the last hour of incubation. The remain-
ing cells were used to measure total 35S-labeled VMAT2 for each
time interval. Cells were harvested in 50 mM Tris (pH 7.5), 150 mM
NaCl, 10 mM EDTA, 5 mM EGTA, 1% Triton X-100, 0.2% SDS, 20
mg/ml PMSF, 2 mg/ml pepstatin, 2 mg/ml leupeptin (immunoprecipi-
tation, or IP buffer) and postnuclear supernatants from cells that
had been incubated in HA.11 were incubated with protein G-aga-
rose. To detect total VMAT2, the remaining supernatants were incu-
bated with HA.11 prebound to protein G-agarose. After overnight in-
cubation at 4ºC, the protein G-agarose was sedimented, washed,
the proteins eluted with SDS sample buffer, separated by electro-
phoresis through SDS-polyacrylamide, and submitted to autoradi-
ography. The films were optically scanned, quantified using NIH Im-
age, and the amount of 35S-labeled VMAT2 detected on the cell
surface at 1, 2, and 3 hr expressed as a fraction of total 35S-labeled
VMAT2. The experiment was performed two to three independent
times for each VMAT2 construct.
Primary Hippocampal Culture, Transfection,
and Immunofluorescence
Hippocampi from embryonic day 19 (E19) rats were dissociated in
Hanks’ Balanced Salt Solution (HBSS) containing trypsin/EDTA
(Gibco BRL) for 25 min at 37ºC, treated with trypsin inhibitor for 5
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631min, washed in DMEM (Gibco BRL) containing 10% FBS, triturated,
resuspended in fresh DMEM/10% FBS, and electroporated with 3 mg
DNA per 3–5 3 106 cells (Amaxa). After transfection, the cells were
plated in complete NB (Neurobasal medium containing 2% B27/
1% GlutaMAX/penicillin-streptomycin/20 mM HEPES [pH 7.4]) at
a density of 100,000 per 12 mm poly-L-lysine-coated coverslip (for
immunofluorescence) and 2 3 106 per well in a 6-well plate (for bio-
chemical analysis). Cultures were fed by replacing half the media
with fresh media every 3–5 days.
Transfected primary hippocampal cultures grown for 12–18 days
in vitro were fixed, permeabilized, and blocked in phosphate-
buffered saline (PBS) containing 0.02% saponin/1% fish gelatin/
5% BSA before immunostaining for HA with rat anti-HA 3F10 (Roche)
and mouse HA11 (Covance), for MAP2 with mouse HM2 mAb
(Sigma), and for SV2 with a mouse mAb (a generous gift of R. Kelly).
Monoclonal antibodies to EEA1 (1:50) and PSD-95 were obtained
from BD Biosciences and Affinity BioReagents, respectively, and
rabbit polyclonal antibodies to GluR1 and GFP from Chemicon
and Molecular Probes, respectively. The immune deposits were de-
tected with donkey anti-rabbit antibodies conjugated to FITC, don-
key anti-mouse, -rat, or -rabbit antibodies conjugated to Cy3, and/or
donkey anti-mouse, -rat, or -rabbit antibodies conjugated to Cy5.
Antibody Uptake by Hippocampal Neurons
Transfected embryonic hippocampal neurons grown 10–12 days in
vitro were labeled for 30 min at 4ºC in NB containing 1:100 mouse
HA antibody conjugated directly to the Alexa 488 fluorophore (HA-
488, Covance), rinsed, and incubated at 37ºC for 0–20 min before in-
ternalization was stopped with NB at 4ºC. To identify internalized
VMAT2, the remaining cell-surface fluorophore was quenched for
40 min at 4ºC with rabbit anti-Alexa 488 (Molecular Probes) diluted
1:10 in NB. Unquenched control neurons were incubated for the
same time without anti-Alexa 488. After washing, the cells were fixed
and immunostained with mouse HA.11 as above, followed by don-
key anti-mouse antibody conjugated to Cy3. Antibody feeding ex-
periments were performed by incubating the transfected neurons
for 2 and 5 min with HA-488 in complete NB/2%FBS at 37ºC before
washing in cold NB, fixation, and immunostaining with mouse HA.11
antibody, followed by secondary donkey anti-mouse antibody con-
jugated to Cy3. The immunofluorescence from multiple cultures
transfected at different times was imaged by confocal microscopy,
quantified using Zeiss software, and areas drawn to cover the pro-
cesses of individual transfected neurons used to calculate the ratio
of surface-labeled to total VMAT2 fluorescence. Since different anti-
bodies were used to detect the surface and total transporter, the ra-
tio of surface/total fluorescence is arbitrary. One-way ANOVA was
used for the statistical analysis.
Cell-Surface Biotinylation
Hippocampal cultures were maintained for 12–13 days after trans-
fection, washed, chilled on ice for 10–20 min, and incubated with
gentle agitation for 30 min with freshly prepared 0.5–0.8 mg/ml biotin
(Ez-link-sulfo-NHS-SS-Biotin, Pierce) in PBS at 4ºC. The unreacted
biotin was quenched with cold 100 mM glycine for 20 min at 4ºC,
and the cells lysed in 0.2% Triton X-100/150 mM NaCl/25 mM KCl/
10 mM Tris (pH 7.4) (lysis buffer) containing protease inhibitors for
30 min at 4ºC. Biotinylated protein was recovered from the post-
nuclear supernatant by incubation with UltraLink Immobilized
NeutrAvidin (50% slurry, Pierce) for 12–16 hr at 4ºC, eluted in SDS
sample buffer/200 mM DTT, and immunoblotted with rat HA anti-
body 3F10 and a monoclonal mouse NMDAR1 antibody (Phar-
mingen) followed by, respectively, secondary anti-rat and -mouse
antibodies conjugated to HRP (Amersham Biosciences) and detec-
tion by enhanced chemiluminescence. The emission was captured
with a FluorChem Imager (Alpha Innotech), quantified using the
FluorChem software, and one-way ANOVA used for statistical anal-
ysis of three independent experiments.
Stimulation of Transfected Hippocampal Neurons
Hippocampal neurons transfected as above with VMAT2 cDNAs
were rinsed in warm Tyrode’s solution (in mM: 119 NaCl, 2.5 KCl,
2 CaCl2, 2 MgCl2, 30 glucose, 25 HEPES [pH 7.4]) containing
10 mM CNQX to block AMPA receptors and 50 mM APV to block
NMDA receptors, and stimulated for 2 and 5 min at 37ºC in eitherTyrode’s solution containing 90 mM KCl (reducing the NaCl to 31.5
mM), in the same solution without Ca2+ but with 1 mM EGTA, and
in standard Tyrode’s solution. Under all conditions, the cells were in-
cubated in the presence of mouse HA-Alexa 488 antibody to label
surface HA-tagged VMAT2, washed, fixed, and immunostained
with mouse HA.11 antibody for total VMAT2 and rabbit polyclonal
antibody for synaptophysin (Zymed), followed by secondary donkey
anti-mouse antibody conjugated to Cy3 and donkey anti-rabbit an-
tibody conjugated to Cy5. Areas drawn to cover HA+/synaptophy-
sin+ puncta (representing axonal terminals) and HA+/synaptophy-
sin2 puncta (somatodendritic sites) of individual neurons from
multiple cultures were used to calculate the ratio of surface-labeled
versus total fluorescence for wild-type and EE/AA VMAT2. Puncta
not near the cell surface were excluded from the analysis because
we could not have detected the exocytosis of these membranes.
One-way ANOVA was used for the statistical analysis.
Amperometric Recordings
Hippocampal neurons were cultured as previously described from
postnatal rats (Pothos et al., 1998), plated directly onto laminin-
coated coverslips, maintained in vitro for 1 week before transfection
with Effectene (Qiagen), and amperometric recordings performed 1
week after transfection as previously described (Staal et al., 2004).
The cultures were treated with 100 mM L-DOPA for at least 1 hr be-
fore recording, and the amperometry was performed in recording
solution (in mM: 130 NaCl, 2 KCl, 10 HEPES, 1 Na2HPO4, 2 MgCl2,
1.2 CaCl2, w300 mOsm [pH 7.4]) that also contained 100 mM
L-DOPA. Neurons were stimulated with a solution in which 40 mM
KCl was substituted for an equivalent concentration of NaCl by local
perfusion through a glass micropipette (Picospritzer, General Valve,
Fairfield, NJ) for 10 s at 10 psi w30 mm from the recording site. To
detect peaks, the raw amperometric data were collected and ana-
lyzed using a locally written routine in IGOR Pro (Lake Oswego,
OR) available at http://cumc.columbia.edu/dept/neurology/sulzer/
download.html. The comparison between groups was performed
by c2 analysis.
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